Connecting clinical care, data and research
PartnershipsContact
← Back to publications

RESEARCH PUBLICATION / 2026

Correspondence / Letter

Letter: Calendar Era or Antiviral Choice-What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection?

Alimentary pharmacology & therapeutics

Citation & Authors

Aliment Pharmacol Ther. 2026;.

Li-Tong Lin; Cheng-Hsien Hung

Abstract & Original paper

No abstract is available in the public index. Please consult the original paper.

Go to journal page